×
About 355 results

ALLMedicine™ Metered Dose Inhalers Center

Research & Reviews  124 results

Do you know when the inhaler is empty?
https://doi.org/10.1136/archdischild-2022-324027
Archives of Disease in Childhood; Fullwood I, Evans T et. al.

May 14th, 2022 - Medication review is recommended at asthma appointments. The presence of propellant in the metered dose inhalers (MDIs) makes it challenging to identify when the inhaler is empty. The COVID-19 pandemic has resulted in move towards more virtual mon...

Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Dru...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097569
Pharmaceutical Research; Kumar R, Mehta P et. al.

May 14th, 2022 - Respiratory disorders pose a major threat to the morbidity and mortality to public health. Here we reviewed the nanotechnology based pulmonary drug delivery using metered dose inhalers. Major respiratory diseases such as chronic obstructive pulmon...

Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
https://clinicaltrials.gov/ct2/show/NCT03615248

Apr 8th, 2022 - Improper inhaler technique can significantly affect the amount of medication reaching the lungs and patients with the incorrect technique are likely to have poorly controlled asthma and more emergency department visits. Studies have shown that up ...

Small Devices, Big Problems: Addressing the Global Warming Potential of Metered Dose In...
https://doi.org/10.1513/AnnalsATS.202202-131VP
Annals of the American Thoracic Society; Rabin AS, Harlan EA et. al.

Feb 26th, 2022 - Small Devices, Big Problems: Addressing the Global Warming Potential of Metered Dose Inhalers.|2022|Rabin AS,Harlan EA,Ambinder AJ,|

Principles for Management of Extractables and Leachables in Ophthalmic Drug Products.
https://doi.org/10.5731/pdajpst.2022.012744
PDA Journal of Pharmaceutical Science and Technology; Houston C, Rodrigues AD et. al.

Feb 17th, 2022 - Ophthalmic solutions and suspensions have long been classified into a high risk category with respect to concerns over extractables and leachables (E&L), though specific guidance on the management of leachables in these products is generally absen...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  8 results

Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
https://clinicaltrials.gov/ct2/show/NCT03615248

Apr 8th, 2022 - Improper inhaler technique can significantly affect the amount of medication reaching the lungs and patients with the incorrect technique are likely to have poorly controlled asthma and more emergency department visits. Studies have shown that up ...

Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients
https://clinicaltrials.gov/ct2/show/NCT02447575

Oct 9th, 2020 - Metered Dose Inhaler (MDI) and Dry Powdered Inhaler (DPI) are the two most common platforms to deliver medicine for patients suffering from Asthma and chronic obstructive pulmonary disease, and are used for dispensing both controller and rescue me...

Breath-actuated Nebulizers in Acute COPD Exacerbations
https://clinicaltrials.gov/ct2/show/NCT03985748

Oct 8th, 2020 - Overview: Effective administration of aerosolized medications depends on the patient's age, physical and cognitive ability the delivery system, and the patient-device interface. Physical ability means the patient's ability to use a specific device...

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
https://clinicaltrials.gov/ct2/show/NCT02624505

Jul 25th, 2019 - This study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product in terms of FEV1 measured at different time-points, using bronchoprovocation (methacholine challenge testing) in adult patients with stabl...

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
https://clinicaltrials.gov/ct2/show/NCT03480997

Mar 29th, 2018 - A single center, open label, single dose study to demonstrate the pharmacodynamic bioequivalence of the test and reference metered dose inhalers containing albuterol sulfate or albuterol sulfate/ipratropium in adult patients with COPD.

see more →

News  9 results

BRIEF-GSK Announces £50m Investment In Renewable Energy And Carbon Reduction
https://www.reuters.com/article/brief-gsk-announces-50m-investment-in-re/brief-gsk-announces-50m-investment-in-renewable-energy-and-carbon-reduction-idUSFWN2QK04U

Sep 20th, 2021 - Sept 20 (Reuters) - GlaxoSmithKline PLC: * PRESS RELEASE: GSK ANNOUNCES MAJOR RENEWABLE ENERGY INVESTMENT AND LOW CARBON INHALER PROGRAMME ALONGSIDE LIFE SCIENCES SECTOR RACE TO ZERO ‘BREAKTHROUGH’ AT NYC CLIMATE WEEK * GSK - ANNOUNCES £50M INVEST...

FDA approves generic to commonly used inhaler as demand surges due to coronavirus
https://www.reuters.com/article/us-fda-cipla/fda-approves-generic-to-commonly-used-inhaler-as-demand-surges-due-to-coronavirus-idUSKCN21Q323

Apr 9th, 2020 - (Reuters) - The U.S Food and Drug Administration on Wednesday approved reut.rs/2RnpE3h first generic of a commonly used albuterol sulfate-based inhaler, catering to increased demand from COVID-19 patients suffering from breathing difficulties. Ind...

Olympic Athlete Backs Call to Cut Inhaler Carbon Footprint 
https://www.medscape.com/viewarticle/914531

Jun 18th, 2019 - Olympic swimming gold medallist Rebecca Adlington has said she was "shocked" to hear claims that 5 doses from an asthma inhaler could generate the same amount of carbon as a 9-mile car trip. It followed new evidence from the National Institute for...

CPG Sec. 160.900 Prescription Drug Marketing Act -- Pedigree Requirements under 21 CFR Part 203
http://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-160900-prescription-drug-marketing-act-pedigree-requirements-under-21-cfr-part-203

Docket Number: FDA-2006-D-0160, FDA-1992-N-0056, FDA-1988-N-0003 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Purpose This document is intended to clarify for FDA personnel and the regulated industry how the agency in...

Upcoming Product-Specific Guidances for Complex Generic Drug Product Development
http://www.fda.gov/drugs/guidances-drugs/upcoming-product-specific-guidances-complex-generic-drug-product-development

Introduction This web page provides information related to upcoming new and revised product-specific guidances (PSGs) to support the development and approval of safe and effective complex generic drug products. What is a complex generic drug produ...

see more →